## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_20 0.8% below STRENGTH zone (4.0-10.0%); PEG 1.99 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($141.12)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Lam Research (LRCX) Stock Is Up, What You Need To Know**
- Source: Finviz | 20251215T200828 | Somewhat-Bullish | Relevance: 100%
- Shares of Lam Research (NASDAQ:LRCX) jumped after a Jefferies analyst maintained a "Buy" rating and increased the price target to $200 from $175, reflecting confidence in the company's future growth. The stock saw a 3.2% rise initially, settling at $165.10, up 2.9% from its previous close. This positive movement follows a prior price target increase by Morgan Stanley and occurs amidst broad strength in the chip-making sector, with LRCX up 128% year-to-date.

**2. Farmers Trust Co. Purchases 13,136 Shares of Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251215T101236 | Bullish | Relevance: 100%
- Farmers Trust Co. has increased its stake in Lam Research Corporation (NASDAQ:LRCX) by 30.1%, acquiring an additional 13,136 shares, bringing its total holdings to 56,710 shares valued at $7.59 million. This makes Lam Research the firm's 18th largest position, accounting for 1.3% of its portfolio. The semiconductor company recently beat Q3 earnings estimates and received several analyst target price increases, although insiders have been net sellers.

**3. Lam Research Corp. stock outperforms competitors despite losses on the day**
- Source: MarketWatch | 20251217T163000 | Neutral | Relevance: 100%
- Lam Research Corp. (LRCX) shares fell 5.07% to $154.98 on Wednesday, marking its second consecutive day of losses. Despite this decline, the stock outperformed the broader market, as the S&P 500 Index and Dow Jones Industrial Average also experienced significant losses.

**4. Sanders Morris Harris LLC Acquires New Position in Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251217T130934 | Somewhat-Bullish | Relevance: 100%
- Sanders Morris Harris LLC has acquired a new position in Lam Research Corporation, purchasing 42,420 shares valued at approximately $5.68 million, making it their 18th largest holding. Lam Research recently surpassed quarterly earnings and revenue estimates, issuing positive Q2 2026 guidance. While institutional ownership is high at 84.61% and analysts rate it a "Moderate Buy," insiders have sold a significant number of shares recently.

**5. Lam Research Corporation $LRCX Shares Bought by Aaron Wealth Advisors LLC**
- Source: MarketBeat | 20251216T080837 | Bullish | Relevance: 100%
- Aaron Wealth Advisors LLC significantly increased its stake in Lam Research Corporation ($LRCX) by 90.9% in Q3, acquiring an additional 11,612 shares to hold a total of 24,382 shares valued at approximately $3.27 million. This move comes as Lam Research exceeded Q3 estimates and analysts maintain a "Moderate Buy" consensus rating with an average target price of $156.21. The article also details other institutional investor activities, analyst forecasts, and recent insider transactions for the semiconductor company.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Mizuho | $200 | $170 | +18% |
| 2025-12-15 | Jefferies | $200 | $175 | +14% |
| 2025-12-02 | Morgan Stanley | $158 | $137 | +15% |
| 2025-11-25 | UBS | $175 | $165 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Mizuho | main | Outperform |
| 2025-12-15 | Jefferies | main | Buy |
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-25 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 6 ($14.07M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-6.3% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $14M sold (6 transactions in 90 days).
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Analyst target momentum: 4 raises (avg +13%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.99 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (4 raises, avg +13%). Insider selling cluster ($14.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $195.4B |
| Beta | 1.78 |
| 52W Range | $56.32 - $169.69 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.99 |
| Forward P/E | 27.6 |
| Current P/E | 32.0 |
| YoY Growth | 16.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 7.0% to 0.8% (-6.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.2pp (needs >4.0% for momentum thesis). MRS_5 (-2.7%) diverging from MRS_20 - short-term weakness emerging. Long-term uptrend intact (above SMA200 at 1.44x) but short-term weakness (below SMA20). RSI neutral at 48. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.77% (CS: 36) | Neutral |
| RSI_14 | 47.6 | Neutral |
| MACD Histogram | -0.33 | Bearish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 1.011x | Above |
| vs SMA200 | 1.439x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $154.98
- **Stop Loss:** $141.12 (8.9% risk)
- **Target:** $168.84 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 32
- **Position Value:** $4,959.36
- **Portfolio %:** 4.96%
- **Risk Dollars:** $450.00
- **Risk Per Trade:** 0.45%
- **Modifiers:** L1 90% | L2 50% | Combined 0.45x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-07 01:41 | MRS_20*